- Tytuł:
- Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration
- Autorzy:
- Źródło:
- In Multiple Sclerosis and Related Disorders April 2022 60
Czasopismo naukowe